Lupin Limited has informed the Exchange about press release dated 06-May-2022 titled Lupin Receives Approval from U.S. FDA for Iloperidone Tablets.
Lupin Limited has informed the Exchange about press release dated 06-May-2022 titled Lupin Receives Approval from U.S. FDA for Iloperidone Tablets.